An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer-Reference-Cited by-同舟云学术

An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer

Published:2007-11 Issue:10 Volume:18 Page:1213-1219
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lin Yung-Chang,Chang Hsien-Kun,Shen Wen-Chi,Chen Jen-Shi,Wang Hung-Ming

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference32 articles.

1. Recent progress in the clinical development of docetaxel (taxotere);Hortobagyi;Semin Oncol,1999

2. A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer;Crown;Semin Oncol,1999

3. Docetaxel vs. doxorubicin in patients with metastatic breast cancer who have failed alkylating chemotherapy: a preliminary report of the randomized phase III trial;Aapro;Semin Oncol,1998

4. Phase III randomized trials of docetaxel in patients with metastatic breast cancer;Crown;Semin Oncol,1999

5. Adjuvant docetaxel for node-positive breast cancer;Martin;N Engl J Med,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local microRNA delivery targets Palladin and prevents metastatic breast cancer;Nature Communications;2016-09-19

2. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer;Journal of Experimental & Clinical Cancer Research;2015-08-22

3. Neem leaf glycoprotein is superior than Cisplatin and Sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment;International Immunopharmacology;2013-09

4. Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer;Annals of Oncology;2013-05

5. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer;Journal of Clinical Pharmacy and Therapeutics;2011-09-26